|
1
|
Ehmann LM, Ruzicka T and Wollenberg A:
Cutaneous side-effects of EGFR inhibitors and their management.
Skin Therapy Lett. 16:1–3. 2011.PubMed/NCBI
|
|
2
|
Baas JM, Krens LL, Guchelaar HJ, Ouwerkerk
J, de Jong FA, Lavrijsen AP and Gelderblom H: Recommendations on
management of EGFR inhibitor-induced skin toxicity: A systematic
review. Cancer Treat Rev. 38:505–514. 2012. View Article : Google Scholar
|
|
3
|
Pomerantz RG, Mirvish ED and Geskin LJ:
Cutaneous reactions to epidermal growth factor receptor inhibitors.
J Drugs Dermatol. 9:1229–1234. 2010.PubMed/NCBI
|
|
4
|
Reck M and Gutzmer R: Management of the
cutaneous side effects of therapeutic epidermal growth factor
receptor inhibition. Onkologie. 33:470–479. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Overgaard CE, Daugherty BL, Mitchell LA
and Koval M: Claudins: Control of barrier function and regulation
in response to oxidant stress. Antioxid Redox Signal. 15:1179–1193.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morita K, Miyachi Y and Furuse M: Tight
junctions in epidermis: From barrier to keratinization. Eur J
Dermatol. 21:12–17. 2011.PubMed/NCBI
|
|
7
|
Kirschner N, Bohner C, Rachow S and
Brandner JM: Tight junctions: Is there a role in dermatology? Arch
Dermatol Res. 302:483–493. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Furuse M, Hata M, Furuse K, Yoshida Y,
Haratake A, Sugitani Y, Noda T, Kubo A and Tsukita S: Claudin-based
tight junctions are crucial for the mammalian epidermal barrier: A
lesson from claudin-1-deficient mice. J Cell Biol. 156:1099–1111.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hadj-Rabia S, Baala L, Vabres P,
Hamel-Teillac D, Jacquemin E, Fabre M, Lyonnet S, De Prost Y,
Munnich A, Hadchouel M, et al: Claudin-1 gene mutations in neonatal
sclerosing cholangitis associated with ichthyosis: A tight junction
disease. Gastroenterology. 127:1386–1390. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Turksen K and Troy TC: Barriers built on
claudins. J Cell Sci. 117:2435–2447. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tran QT, Kennedy LH, Leon Carrion S,
Bodreddigari S, Goodwin SB, Sutter CH and Sutter TR: EGFR
regulation of epidermal barrier function. Physiol Genomics.
44:455–469. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
13
|
Zhang J, Ni C, Yang Z, Piontek A, Chen H,
Wang S, Fan Y, Qin Z and Piontek J: Specific binding of Clostridium
perfringens enterotoxin fragment to Claudin-b and modulation of
zebrafish epidermal barrier. Exp Dermatol. 24:605–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adam AP: Regulation of endothelial
adherens junctions by tyrosine phosphorylation. Mediators Inflamm.
2015:2728582015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alsaffar H, Martino N, Garrett JP and Adam
AP: Interleukin-6 promotes a sustained loss of endothelial barrier
function via Janus kinase-mediated STAT3 phosphorylation and de
novo protein synthesis. Am J Physiol Cell Physiol. 314:C589–C602.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sharma V, Singh SK, Anderson D, Tobin DJ
and Dhawan A: Zinc oxide nanoparticle induced genotoxicity in
primary human epidermal keratinocytes. J Nanosci Nanotechnol.
11:3782–3788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mikami D, Sakai S, Sasaki S and Igarashi
Y: Effects of asterias amurensis-derived sphingoid bases on the de
novo ceramide synthesis in cultured normal human epidermal
keratinocytes. J Oleo Sci. 65:671–680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Szöllősi AG, Gueniche A, Jammayrac O,
Szabó-Papp J, Blanchard C, Vasas N, Andrási M, Juhász I, Breton L
and Bíró T: Bifidobacterium longum extract exerts
pro-differentiating effects on human epidermal keratinocytes, in
vitro. Exp Dermatol. 26:92–94. 2017. View Article : Google Scholar
|
|
19
|
Dang NN, Pang SG, Song HY, An LG and Ma
XL: Filaggrin silencing by shRNA directly impairs the skin barrier
function of normal human epidermal keratinocytes and then induces
an immune response. Braz J Med Biol Res. 48:39–45. 2015. View Article : Google Scholar :
|
|
20
|
Woo SW, Rhim DB, Kim C and Hwang JK:
Effect of standardized boesenbergia pandurata extract and its
active compound panduratin A on skin hydration and barrier function
in human epidermal keratinocytes. Prev Nutr Food Sci. 20:15–21.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mullin JM, Laughlin KV, Ginanni N, Marano
CW, Clarke HM and Peralta Soler A: Increased tight junction
permeability can result from protein kinase C
activation/translocation and act as a tumor promotional event in
epithelial cancers. Ann N Y Acad Sci. 915:231–236. 2000. View Article : Google Scholar
|
|
22
|
Flores-Benitez D, Rincon-Heredia R,
Razgado LF, Larre I, Cereijido M and Contreras RG: Control of tight
junctional sealing: Roles of epidermal growth factor and
prostaglandin E2. Am J Physiol Cell Physiol. 297:C611–C620. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Flores-Benítez D, Ruiz-Cabrera A,
Flores-Maldonado C, Shoshani L, Cereijido M and Contreras RG:
Control of tight junctional sealing: Role of epidermal growth
factor. Am J Physiol Renal Physiol. 292:F828–F836. 2007. View Article : Google Scholar
|
|
24
|
Kojima T, Yamamoto T, Lan M, Murata M,
Takano K, Go M, Ichimiya S, Chiba H and Sawada N: Inhibition of MAP
kinase activity moderates changes in expression and function of
Cx32 but not claudin-1 during DNA synthesis in primary cultures of
rat hepatocytes. Med Electron Microsc. 37:101–113. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Furuse M, Fujita K, Hiiragi T, Fujimoto K
and Tsukita S: Claudin-1 and -2: Novel integral membrane proteins
localizing at tight junctions with no sequence similarity to
occludin. J Cell Biol. 141:1539–1550. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Amasheh S, Meiri N, Gitter AH, Schöneberg
T, Mankertz J, Schulzke JD and Fromm M: Claudin-2 expression
induces cation-selective channels in tight junctions of epithelial
cells. J Cell Sci. 115:4969–4976. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosenthal R, Milatz S, Krug SM, Oelrich B,
Schulzke JD, Amasheh S, Günzel D and Fromm M: Claudin-2, a
component of the tight junction, forms a paracellular water
channel. J Cell Sci. 123:1913–1921. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Muto S, Hata M, Taniguchi J, Tsuruoka S,
Moriwaki K, Saitou M, Furuse K, Sasaki H, Fujimura A, Imai M, et
al: Claudin-2-deficient mice are defective in the leaky and
cation-selective paracellular permeability properties of renal
proximal tubules. Proc Natl Acad Sci USA. 107:8011–8016. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Furuse M, Furuse K, Sasaki H and Tsukita
S: Conversion of zonulae occludentes from tight to leaky strand
type by introducing claudin-2 into Madin-Darby canine kidney I
cells. J Cell Biol. 153:263–272. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Colegio OR, Van Itallie CM, McCrea HJ,
Rahner C and Anderson JM: Claudins create charge-selective channels
in the paracellular pathway between epithelial cells. Am J Physiol
Cell Physiol. 283:C142–C147. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Colegio OR, Van Itallie C, Rahner C and
Anderson JM: Claudin extracellular domains determine paracellular
charge selectivity and resistance but not tight junction fibril
architecture. Am J Physiol Cell Physiol. 284:C1346–C1354. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hou J, Gomes AS, Paul DL and Goodenough
DA: Study of claudin function by RNA interference. J Biol Chem.
281:36117–36123. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ikari A, Takiguchi A, Atomi K and Sugatani
J: Epidermal growth factor increases clathrin-dependent endocytosis
and degradation of claudin-2 protein in MDCK II cells. J Cell
Physiol. 226:2448–2456. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Singh AB and Harris RC: Epidermal growth
factor receptor activation differentially regulates claudin
expression and enhances transepithelial resistance in Madin-Darby
canine kidney cells. J Biol Chem. 279:3543–3552. 2004. View Article : Google Scholar
|
|
35
|
Findley MK and Koval M: Regulation and
roles for claudin-family tight junction proteins. IUBMB Life.
61:431–437. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
García-Hernández V, Flores-Maldonado C,
Rincon-Heredia R, Verdejo-Torres O, Bonilla-Delgado J,
Meneses-Morales I, Gariglio P and Contreras RG: EGF regulates
claudin-2 and -4 expression through Src and STAT3 in MDCK cells. J
Cell Physiol. 230:105–115. 2015. View Article : Google Scholar
|
|
37
|
Singh AB, Sharma A and Dhawan P: Claudin-1
expression confers resistance to anoikis in colon cancer cells in a
Src-dependent manner. Carcinogenesis. 33:2538–2547. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ogawa Y, Kiba T, Nakano K, Fujiwara K,
Taniguchi H, Hosokawa A, Nakashima T, Kimoto S, Kajiume S, Okada Y,
et al: Prospective study of biotin treatment in patients with
erythema due to gefitinib or erlotinib. Gan To Kagaku Ryoho.
41:517–522. 2014.In Japanese. PubMed/NCBI
|
